首页 > 最新文献

Malaysian Family Physician最新文献

英文 中文
Variant of Hoffa disease: a case report. 变异Hoffa病1例报告。
Q3 Nursing Pub Date : 2025-06-24 eCollection Date: 2025-01-01 DOI: 10.51866/cr.819
Sharifah Nor Amirah Syed Abdul Latiff Alsagoff, Mohd Fairudz Mohd Miswan, Mohd Yusoff Yahaya, Mohamed Faizal Sikkandar, Anis Safura Ramli

This report presents the case of an 18-year-old female student with a low BMI, who was otherwise healthy. She presented with chronic anterior right knee pain persisting for 1 year. The pain began spontaneously and gradually increased in severity, especially during long distance walking and standing for more than 15 minutes. The symptoms did not subside with medication and physiotherapy. All biochemical and radiological investigations to rule out other related possible aetiologies were unremarkable. The patient eventually underwent an arthroscopic knee surgery, during which the intraoperative findings revealed the Hoffa fat pad over the anteromedial knee joint. This was debrided and after surgery, she was symptom free and had resumed her normal activities.

本报告报告了一名18岁的女学生,身体质量指数低,其他方面健康。她表现为慢性右膝前痛,持续1年。疼痛开始是自发的,并逐渐加重,特别是在长距离行走和站立超过15分钟时。药物和物理治疗均未使症状减轻。所有排除其他相关可能病因的生化和放射学检查均无显著差异。患者最终接受了膝关节镜手术,术中发现膝关节前内侧有Hoffa脂肪垫。手术后,她的症状消失,并恢复了正常的活动。
{"title":"Variant of Hoffa disease: a case report.","authors":"Sharifah Nor Amirah Syed Abdul Latiff Alsagoff, Mohd Fairudz Mohd Miswan, Mohd Yusoff Yahaya, Mohamed Faizal Sikkandar, Anis Safura Ramli","doi":"10.51866/cr.819","DOIUrl":"10.51866/cr.819","url":null,"abstract":"<p><p>This report presents the case of an 18-year-old female student with a low BMI, who was otherwise healthy. She presented with chronic anterior right knee pain persisting for 1 year. The pain began spontaneously and gradually increased in severity, especially during long distance walking and standing for more than 15 minutes. The symptoms did not subside with medication and physiotherapy. All biochemical and radiological investigations to rule out other related possible aetiologies were unremarkable. The patient eventually underwent an arthroscopic knee surgery, during which the intraoperative findings revealed the Hoffa fat pad over the anteromedial knee joint. This was debrided and after surgery, she was symptom free and had resumed her normal activities.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"41"},"PeriodicalIF":0.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When patients present with bulging eyes: A case series of proptosis. 当患者出现眼球突出时:眼球突出系列1例。
Q3 Nursing Pub Date : 2025-06-14 eCollection Date: 2025-01-01 DOI: 10.51866/cr.783
Nur Azuriah Abidin, Ilham Ameera Ismail, Siti Nuradliah Jamil, Norasyikin Mustafa

Proptosis, commonly referred to as 'bulging eyes', is characterised by abnormal protrusion of the eyeball. This condition can arise from a variety of underlying causes, including thyroid eye disease, orbital tumours, inflammatory disorders and vascular anomalies. Timely recognition of proptosis and the underlying cause is crucial due to potentially vision-threatening conditions. We present a case series of patients who presented with proptosis and proptosis-like condition in a primary care clinic. All cases exhibited bulging of the eyes with protrusion beyond 21 mm from the orbital rim. The first case involved proptosis due to cavernous haemangioma; the second was a case of pseudoproptosis; and the final case was Oue so underlying thyroid eye disease. A comprehensive evaluation, including detailed historn-taVing and radiological imaging, was essential in identifying the specific causes of proptosis for each case, thus allowing for appropriate management strategies to be implemented.

眼球突出,通常被称为“凸出的眼睛”,其特征是眼球异常突出。这种情况可由多种潜在原因引起,包括甲状腺眼病、眼眶肿瘤、炎症性疾病和血管异常。由于潜在的视力威胁条件,及时识别突出及其潜在原因至关重要。我们提出了一个病例系列的病人谁提出了突出和突出样条件在初级保健诊所。所有病例均表现为眼球突出,距眶缘超过21毫米。第一个病例涉及海绵状血管瘤引起的突起;第二例为假突出;最后一个病例是甲状腺眼病。全面的评估,包括详细的病史记录和放射成像,对于确定每个病例突出的具体原因至关重要,从而允许实施适当的管理策略。
{"title":"When patients present with bulging eyes: A case series of proptosis.","authors":"Nur Azuriah Abidin, Ilham Ameera Ismail, Siti Nuradliah Jamil, Norasyikin Mustafa","doi":"10.51866/cr.783","DOIUrl":"10.51866/cr.783","url":null,"abstract":"<p><p>Proptosis, commonly referred to as 'bulging eyes', is characterised by abnormal protrusion of the eyeball. This condition can arise from a variety of underlying causes, including thyroid eye disease, orbital tumours, inflammatory disorders and vascular anomalies. Timely recognition of proptosis and the underlying cause is crucial due to potentially vision-threatening conditions. We present a case series of patients who presented with proptosis and proptosis-like condition in a primary care clinic. All cases exhibited bulging of the eyes with protrusion beyond 21 mm from the orbital rim. The first case involved proptosis due to cavernous haemangioma; the second was a case of pseudoproptosis; and the final case was Oue so underlying thyroid eye disease. A comprehensive evaluation, including detailed historn-taVing and radiological imaging, was essential in identifying the specific causes of proptosis for each case, thus allowing for appropriate management strategies to be implemented.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report. 阿托伐他汀揭露原发性胆道胆管炎和自身免疫性肝炎重叠综合征在老年人:一个病例报告。
Q3 Nursing Pub Date : 2025-06-13 eCollection Date: 2025-01-01 DOI: 10.51866/cr.853
Hashim Khadijat-Ul-Kurba, Hamzah Zuhra, Osman Ummul Afilah, Rosli Nurwahyuna

Although statins are generally well-tolerated, recent reports have linked their use to autoimmune liver disease. We present the case of a 70-year-old woman who developed hepatocellular injury 4 months after switching from simvastatin to high-intensity atorvastatin. Discontinuation of atorvastatin led to a gradual improvement in liver function over 3 months; however, her rising LDL(low-density lipoprotein) levels prompted a rechallenge with simvastatin, resulting in recurrent liver function derangement. Despite cessation, the liver enzyme levels continued to rise. Positive autoantibodies, including antinuclear antibodies, anti-mitochondrial M2 and immunoglobulins (i.e. IgA and IgG), along with a liver biopsy, confirmed an overlapping syndrome of primary biliary cholangitis and autoimmune hepatitis. Treatment with prednisolone led to normalisation of liver function, and the patient remained stable on azathioprine and ursodeoxycholic acid. This case underscores the importance of vigilant liver function monitoring, caution when rechallenging statins and the potential for statin therapy to unmask underlying autoimmune liver disease.

尽管他汀类药物通常耐受性良好,但最近的报道将其与自身免疫性肝病联系起来。我们报告了一位70岁的女性,在从辛伐他汀转向高强度阿托伐他汀4个月后发生肝细胞损伤。停用阿托伐他汀导致肝功能在3个月内逐渐改善;然而,她的LDL(低密度脂蛋白)水平升高促使她再次使用辛伐他汀,导致肝功能紊乱复发。尽管停止,肝酶水平继续上升。自身抗体阳性,包括抗核抗体、抗线粒体M2和免疫球蛋白(即IgA和IgG),以及肝脏活检,证实原发性胆管炎和自身免疫性肝炎重叠综合征。强的松龙治疗导致肝功能正常化,患者在硫唑嘌呤和熊去氧胆酸治疗下保持稳定。该病例强调了警惕肝功能监测的重要性,重新挑战他汀类药物时要谨慎,以及他汀类药物治疗潜在的自身免疫性肝病的潜力。
{"title":"Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report.","authors":"Hashim Khadijat-Ul-Kurba, Hamzah Zuhra, Osman Ummul Afilah, Rosli Nurwahyuna","doi":"10.51866/cr.853","DOIUrl":"10.51866/cr.853","url":null,"abstract":"<p><p>Although statins are generally well-tolerated, recent reports have linked their use to autoimmune liver disease. We present the case of a 70-year-old woman who developed hepatocellular injury 4 months after switching from simvastatin to high-intensity atorvastatin. Discontinuation of atorvastatin led to a gradual improvement in liver function over 3 months; however, her rising LDL(low-density lipoprotein) levels prompted a rechallenge with simvastatin, resulting in recurrent liver function derangement. Despite cessation, the liver enzyme levels continued to rise. Positive autoantibodies, including antinuclear antibodies, anti-mitochondrial M2 and immunoglobulins (i.e. IgA and IgG), along with a liver biopsy, confirmed an overlapping syndrome of primary biliary cholangitis and autoimmune hepatitis. Treatment with prednisolone led to normalisation of liver function, and the patient remained stable on azathioprine and ursodeoxycholic acid. This case underscores the importance of vigilant liver function monitoring, caution when rechallenging statins and the potential for statin therapy to unmask underlying autoimmune liver disease.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"34"},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of the pilot project Nephrology Liaison Clinic in a primary care clinic: A retrospective observational study. 初级保健诊所肾内科联络诊所试点项目的临床结果:一项回顾性观察研究。
Q3 Nursing Pub Date : 2025-06-13 eCollection Date: 2025-01-01 DOI: 10.51866/oa.762
Tiong Lim Low, Ismail Rohayah, Bavanandan Sunita, Abdul Wahab Mohamad Zaimi, Wan Mohamad Hazlina Wan

Introduction: The pilot project Nephrology Liaison Clinic, initiated in 2019 at Klinik Kesihatan Sentul, integrates nephrology services into primary care. Managed by primary care physicians with periodic nephrologist input, this project aims to enhance early intervention and reduce tertiary care burdens.

Methods: In this retrospective study, the clinical outcomes of patients enrolled from 2019 to 2021 were analysed. Patients with chronic kidney disease stage G3 or stage G4/G5 declining hospital referral and those with persistent proteinuria were included. Patients who were lost to follow-up, deceased or transferred to other clinics were excluded. Data analysis included descriptive statistics, the chi-square test, Fisher's exact test and McNemar test.

Results: A total of 73 patients were included. After 1 year, 45 (61.6%) remained under primary care, while 28 (38.4%) required tertiary referral, predominantly for renal replacement therapy preparation. Among the primary care patients, 71.1% (32/45) either had maintained or slowed estimated glomerular filtration rate decline. Ten patients had their HbA1c improved from >8% to <8% (p = 0.002), and 13 more patients were initiated on sodium-glucose cotransporter-2 inhibitors compared to baseline (p < 0.001).

Conclusion: This study demonstrates the feasibility of nephrology liaison clinics in stabilising renal function and improving metabolic parameters within primary care settings. The findings highlight the potential of shared-care models in resource-limited settings. However, challenges remain in ensuring adequate human resources and improving access to renoprotective medications. Larger-scale, longterm studies are warranted to validate the long-term benefits and wider applicability of this integrated approach.

导读:Klinik Kesihatan senul于2019年启动了肾病联络诊所试点项目,将肾病服务纳入初级保健。该项目由初级保健医生管理,定期提供肾病专家意见,旨在加强早期干预,减少三级保健负担。方法:回顾性分析2019 - 2021年入组患者的临床结局。包括慢性肾脏疾病G3期或G4/G5期住院转诊下降的患者和持续性蛋白尿患者。未随访、死亡或转移到其他诊所的患者被排除在外。数据分析包括描述性统计、卡方检验、Fisher精确检验和McNemar检验。结果:共纳入73例患者。1年后,45例(61.6%)继续接受初级保健,28例(38.4%)需要三级转诊,主要是肾脏替代治疗准备。在初级保健患者中,71.1%(32/45)维持或减缓了肾小球滤过率的估计下降。结论:本研究表明,在初级保健机构中,肾脏学联络诊所在稳定肾功能和改善代谢参数方面是可行的。研究结果强调了共享医疗模式在资源有限环境下的潜力。然而,在确保充足的人力资源和改善获得肾保护药物方面仍然存在挑战。有必要进行更大规模的长期研究,以验证这种综合方法的长期效益和更广泛的适用性。
{"title":"Clinical outcomes of the pilot project Nephrology Liaison Clinic in a primary care clinic: A retrospective observational study.","authors":"Tiong Lim Low, Ismail Rohayah, Bavanandan Sunita, Abdul Wahab Mohamad Zaimi, Wan Mohamad Hazlina Wan","doi":"10.51866/oa.762","DOIUrl":"10.51866/oa.762","url":null,"abstract":"<p><strong>Introduction: </strong>The pilot project Nephrology Liaison Clinic, initiated in 2019 at Klinik Kesihatan Sentul, integrates nephrology services into primary care. Managed by primary care physicians with periodic nephrologist input, this project aims to enhance early intervention and reduce tertiary care burdens.</p><p><strong>Methods: </strong>In this retrospective study, the clinical outcomes of patients enrolled from 2019 to 2021 were analysed. Patients with chronic kidney disease stage G3 or stage G4/G5 declining hospital referral and those with persistent proteinuria were included. Patients who were lost to follow-up, deceased or transferred to other clinics were excluded. Data analysis included descriptive statistics, the chi-square test, Fisher's exact test and McNemar test.</p><p><strong>Results: </strong>A total of 73 patients were included. After 1 year, 45 (61.6%) remained under primary care, while 28 (38.4%) required tertiary referral, predominantly for renal replacement therapy preparation. Among the primary care patients, 71.1% (32/45) either had maintained or slowed estimated glomerular filtration rate decline. Ten patients had their HbA1c improved from >8% to <8% (p = 0.002), and 13 more patients were initiated on sodium-glucose cotransporter-2 inhibitors compared to baseline (p < 0.001).</p><p><strong>Conclusion: </strong>This study demonstrates the feasibility of nephrology liaison clinics in stabilising renal function and improving metabolic parameters within primary care settings. The findings highlight the potential of shared-care models in resource-limited settings. However, challenges remain in ensuring adequate human resources and improving access to renoprotective medications. Larger-scale, longterm studies are warranted to validate the long-term benefits and wider applicability of this integrated approach.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and factors associated with poor sleep quality among patients with hypertension in a primary care clinic: A cross-sectional study. 初级保健诊所高血压患者睡眠质量差的患病率及相关因素:一项横断面研究
Q3 Nursing Pub Date : 2025-06-13 eCollection Date: 2025-01-01 DOI: 10.51866/oa.830
Hong Wea Lau, Siew Mooi Ching, Abu Bakar Fatimah

Introduction: International research has consistently shown that individuals with hypertension experience significantly impaired sleep quality, but there is a lack of study in this field in Malaysia. This study aimed to assess the prevalence and associated factors of poor sleep quality among patients with hypertension in a primary care clinic in Malaysia.

Methods: A cross-sectional study was conducted among patients with hypertension aged 18 years and above in a public health clinic from December 2023 to February 2024. Systematic random sampling was used to recruit participants. Sociodemographic data and relevant information were obtained using the Pittsburgh Sleep Quality Index; Depression, Anxiety and Stress Scale-21; and STOP-BANG questionnaire. The Statistical Package for the Social Sciences version 27 was used to conduct multiple logistic regression analysis of the determinants of poor sleep quality.

Results: A total of 335 participants were recruited, yielding a 98.2% response rate. The mean participant age was 58 years, and 63% were women. The prevalence of poor sleep quality was 87.2%. Multiple logistic regression showed that anxiety symptoms (odds ratio [OR] = 12.279, 95% confidence interval [CI] = 1.573-95.883, P=0.017), low monthly household income (OR=3.573, 95% CI= 1.627-7.847, P=0.002), lack of exercise (0R=2.530, 95% CI=1.108-5.775, P=0.028) and risk of obstructive sleep apnoea (OR=2.521, 95% CI=1.176-5.402, P=0.017) were associated with poor sleep quality.

Conclusion: Poor sleep quality is prevalent among patients with hypertension and is associated with adverse cardiovascular events. Increased awareness among primary care physicians would allow early identification of patients at risk for early intervention.

导言:国际研究一致表明,高血压患者睡眠质量明显受损,但马来西亚缺乏这方面的研究。本研究旨在评估马来西亚一家初级保健诊所高血压患者睡眠质量差的患病率及相关因素。方法:对2023年12月至2024年2月在某公共卫生诊所就诊的18岁及以上高血压患者进行横断面研究。采用系统随机抽样的方法招募参与者。采用匹兹堡睡眠质量指数获取社会人口学数据及相关信息;抑郁、焦虑和压力量表-21;和STOP-BANG问卷。使用社会科学统计软件包第27版对睡眠质量差的决定因素进行多元逻辑回归分析。结果:共招募335名参与者,有效率为98.2%。参与者的平均年龄为58岁,其中63%是女性。睡眠质量差的患病率为87.2%。多元logistic回归分析显示,焦虑症状(比值比[OR] = 12.279, 95%可信区间[CI] = 1.573 ~ 95.883, P=0.017)、家庭月收入低(OR=3.573, 95% CI= 1.627 ~ 7.847, P=0.002)、缺乏锻炼(OR= 2.530, 95% CI=1.108 ~ 5.775, P=0.028)、阻塞性睡眠呼吸暂停风险(OR=2.521, 95% CI=1.176 ~ 5.402, P=0.017)与睡眠质量差相关。结论:睡眠质量差在高血压患者中普遍存在,并与不良心血管事件有关。提高初级保健医生的意识将有助于早期识别有风险的患者,并进行早期干预。
{"title":"Prevalence and factors associated with poor sleep quality among patients with hypertension in a primary care clinic: A cross-sectional study.","authors":"Hong Wea Lau, Siew Mooi Ching, Abu Bakar Fatimah","doi":"10.51866/oa.830","DOIUrl":"10.51866/oa.830","url":null,"abstract":"<p><strong>Introduction: </strong>International research has consistently shown that individuals with hypertension experience significantly impaired sleep quality, but there is a lack of study in this field in Malaysia. This study aimed to assess the prevalence and associated factors of poor sleep quality among patients with hypertension in a primary care clinic in Malaysia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among patients with hypertension aged 18 years and above in a public health clinic from December 2023 to February 2024. Systematic random sampling was used to recruit participants. Sociodemographic data and relevant information were obtained using the Pittsburgh Sleep Quality Index; Depression, Anxiety and Stress Scale-21; and STOP-BANG questionnaire. The Statistical Package for the Social Sciences version 27 was used to conduct multiple logistic regression analysis of the determinants of poor sleep quality.</p><p><strong>Results: </strong>A total of 335 participants were recruited, yielding a 98.2% response rate. The mean participant age was 58 years, and 63% were women. The prevalence of poor sleep quality was 87.2%. Multiple logistic regression showed that anxiety symptoms (odds ratio [OR] = 12.279, 95% confidence interval [CI] = 1.573-95.883, P=0.017), low monthly household income (OR=3.573, 95% CI= 1.627-7.847, P=0.002), lack of exercise (0R=2.530, 95% CI=1.108-5.775, P=0.028) and risk of obstructive sleep apnoea (OR=2.521, 95% CI=1.176-5.402, P=0.017) were associated with poor sleep quality.</p><p><strong>Conclusion: </strong>Poor sleep quality is prevalent among patients with hypertension and is associated with adverse cardiovascular events. Increased awareness among primary care physicians would allow early identification of patients at risk for early intervention.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of the Tuberculosis Diabetes Mellitus-Predictive Tool (TBDM-PT) in primary care. 结核性糖尿病预测工具(TBDM-PT)在初级保健中的发展和验证。
Q3 Nursing Pub Date : 2025-06-10 eCollection Date: 2025-01-01 DOI: 10.51866/oa.708
Ismail Muhammad Ikhwan, Wan Mohammad Wan Mohd Zahiruddin, Zakaria Rosnani, Abdullah Noor Hashimah, Abdullah Hasniza, Mat Jaeb Mat Zuki, Arifin Wan Nor

Introduction: Tuberculosis (TB) is a major public health issue worldwide. Screening patients with diabetes mellitus (DM) for TB incurs the highest cost per TB case discovered. Thus, a more practical and useful screening tool is required, especially at the primary care level. This study sought to develop and validate the Tuberculosis Diabetes Mellitus-Predictive Tool (TBDM-PT) in Kelantan, Malaysia.

Methods: This study included 270 patients with DM (with and without TB) from 2019 to 2021 at health clinics in Kelantan. The variables included in the risk score were chosen using logistic regression analysis. Receiver-operating characteristic curves were used to define the cut-off points for scores indicating a low or high risk of developing TB. Nine experts and 20 healthcare workers were involved in the content and face validation processes, respectively.

Results: The risk score was created using eight different variables. The cut-off point selected was 11 out of 21, with sensitivity and specificity of 81% and 90%, respectively. The content validity index of the scale was 0.93, while the face validity index of each component varied from 0.95 to 1.00.

Conclusion: The newly developed TBDM-PT has great potential as a screening tool for TB among patients with DM at the primary care level. External validation and evaluation of this tool in diverse settings and larger populations are required before being applied into standard diabetes care pathways in primary care facilities.

结核病(TB)是世界范围内的一个重大公共卫生问题。对糖尿病(DM)患者进行结核病筛查导致每发现一例结核病病例的最高费用。因此,需要一种更实用和有用的筛查工具,特别是在初级保健一级。本研究试图在马来西亚吉兰丹开发和验证结核性糖尿病预测工具(TBDM-PT)。方法:本研究纳入了2019年至2021年在吉兰丹州卫生诊所就诊的270例糖尿病患者(伴有和不伴有结核病)。采用logistic回归分析选择纳入风险评分的变量。使用患者工作特征曲线来定义表明患结核病风险低或高的分数的分界点。9名专家和20名医护人员分别参与了内容和面部验证过程。结果:使用8个不同的变量创建风险评分。选取的截断点为21个中的11个,敏感性为81%,特异性为90%。量表的内容效度指数为0.93,各分量的面部效度指数为0.95 ~ 1.00。结论:新开发的TBDM-PT在糖尿病患者的初级保健阶段有很大的潜力作为结核病筛查工具。在将该工具应用于初级保健机构的标准糖尿病护理途径之前,需要在不同的环境和更大的人群中进行外部验证和评估。
{"title":"Development and validation of the Tuberculosis Diabetes Mellitus-Predictive Tool (TBDM-PT) in primary care.","authors":"Ismail Muhammad Ikhwan, Wan Mohammad Wan Mohd Zahiruddin, Zakaria Rosnani, Abdullah Noor Hashimah, Abdullah Hasniza, Mat Jaeb Mat Zuki, Arifin Wan Nor","doi":"10.51866/oa.708","DOIUrl":"10.51866/oa.708","url":null,"abstract":"<p><strong>Introduction: </strong>Tuberculosis (TB) is a major public health issue worldwide. Screening patients with diabetes mellitus (DM) for TB incurs the highest cost per TB case discovered. Thus, a more practical and useful screening tool is required, especially at the primary care level. This study sought to develop and validate the Tuberculosis Diabetes Mellitus-Predictive Tool (TBDM-PT) in Kelantan, Malaysia.</p><p><strong>Methods: </strong>This study included 270 patients with DM (with and without TB) from 2019 to 2021 at health clinics in Kelantan. The variables included in the risk score were chosen using logistic regression analysis. Receiver-operating characteristic curves were used to define the cut-off points for scores indicating a low or high risk of developing TB. Nine experts and 20 healthcare workers were involved in the content and face validation processes, respectively.</p><p><strong>Results: </strong>The risk score was created using eight different variables. The cut-off point selected was 11 out of 21, with sensitivity and specificity of 81% and 90%, respectively. The content validity index of the scale was 0.93, while the face validity index of each component varied from 0.95 to 1.00.</p><p><strong>Conclusion: </strong>The newly developed TBDM-PT has great potential as a screening tool for TB among patients with DM at the primary care level. External validation and evaluation of this tool in diverse settings and larger populations are required before being applied into standard diabetes care pathways in primary care facilities.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute medical care for individuals experiencing homelessness in Kuala Lumpur. 为吉隆坡无家可归者提供紧急医疗服务。
Q3 Nursing Pub Date : 2025-06-10 eCollection Date: 2025-01-01 DOI: 10.51866/mol.927
Khasnur Abd Malek, Ilham Ameera Ismail, Farnaza Ariffin, Md Yasin Mazapuspavina, Raja Ahmad Shaharul
{"title":"Acute medical care for individuals experiencing homelessness in Kuala Lumpur.","authors":"Khasnur Abd Malek, Ilham Ameera Ismail, Farnaza Ariffin, Md Yasin Mazapuspavina, Raja Ahmad Shaharul","doi":"10.51866/mol.927","DOIUrl":"https://doi.org/10.51866/mol.927","url":null,"abstract":"","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"37"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative review of current international atrial fibrillation guidelines from a primary care perspective. 从初级保健的角度对当前国际房颤指南进行比较回顾。
Q3 Nursing Pub Date : 2025-06-07 eCollection Date: 2025-01-01 DOI: 10.51866/cpg.872
Jazlan Jamaluddin, Siok Fuang Liong, Hooi Chin Beh, Karleen Chong, Jin Ian Choong, Ahmad Firdaus Zakaria, Nik Aminah Nik Abdul Kadir

Atrial fibrillation (AF) is the most frequent sustained arrhythmia globally with significant morbidity and mortality. A local guideline has been created to help physicians in clinical decision-making by outlining various generally accepted approaches for the diagnosis, management and prevention of AF. This guideline was published 10 years ago, and it is imperative that new guidelines based on the latest consensus be renewed. Since then, various clinical guidelines have been issued in the past 5 years to standardise the management of AF, including the American College of Cardiology, European Society of Cardiology, National Institute for Health and Care Excellence and Asia Pacific Heart Rhythm Society guidelines. This review aims to provide a comprehensive comparison of these guidelines across multiple aspects of clinical management, including management frameworks, screening, anticoagulation, stroke and bleeding risk assessments, rate and rhythm control, follow-up, comorbidity management and technology usage.

心房颤动(AF)是全球最常见的持续性心律失常,具有显著的发病率和死亡率。通过概述各种公认的AF诊断、管理和预防方法,已经制定了一份当地指南,以帮助医生进行临床决策。该指南是在10年前发布的,迫切需要根据最新共识更新新的指南。从那时起,在过去的5年中,各种临床指南已经发布,以规范AF的管理,包括美国心脏病学会,欧洲心脏病学会,国家健康与护理卓越研究所和亚太心律学会指南。本综述旨在对这些指南在临床管理的多个方面进行全面比较,包括管理框架、筛查、抗凝、中风和出血风险评估、速率和节律控制、随访、合并症管理和技术使用。
{"title":"A comparative review of current international atrial fibrillation guidelines from a primary care perspective.","authors":"Jazlan Jamaluddin, Siok Fuang Liong, Hooi Chin Beh, Karleen Chong, Jin Ian Choong, Ahmad Firdaus Zakaria, Nik Aminah Nik Abdul Kadir","doi":"10.51866/cpg.872","DOIUrl":"10.51866/cpg.872","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is the most frequent sustained arrhythmia globally with significant morbidity and mortality. A local guideline has been created to help physicians in clinical decision-making by outlining various generally accepted approaches for the diagnosis, management and prevention of AF. This guideline was published 10 years ago, and it is imperative that new guidelines based on the latest consensus be renewed. Since then, various clinical guidelines have been issued in the past 5 years to standardise the management of AF, including the American College of Cardiology, European Society of Cardiology, National Institute for Health and Care Excellence and Asia Pacific Heart Rhythm Society guidelines. This review aims to provide a comprehensive comparison of these guidelines across multiple aspects of clinical management, including management frameworks, screening, anticoagulation, stroke and bleeding risk assessments, rate and rhythm control, follow-up, comorbidity management and technology usage.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
World Salt Awareness Week: A call to action for reducing salt intake in Malaysia. 世界食盐意识周:呼吁马来西亚采取行动减少食盐摄入量。
Q3 Nursing Pub Date : 2025-05-27 eCollection Date: 2025-01-01 DOI: 10.51866/cm.929
Yook Chin Chia, Siew Mooi Ching, Nik Sherina Hanafi

Cardiovascular diseases remain a primary contributor to death worldwide, with hypertension being a key determinant. Excessive salt intake is a contributing factor of high blood pressure and cardiovascular diseases. To address this, the World Health Organization recommends keeping daily salt consumption under 5 g and aiming for a 30% decrease by 2025. In Malaysia, efforts to reach this target have faced delays. A local study found that 79% of Malaysians consume an average of 7.9 g of salt per day, which is significantly higher than the WHO's recommendations. Despite efforts such as voluntary food reformulation, mandatory sodium labelling and public education campaigns, challenges remain. Industry reluctance, low consumer awareness and inadequate enforcement slow down such efforts. This commentary reviews these issues and suggests applicable approaches to strengthen Malaysia's salt reduction strategies.

心血管疾病仍然是世界范围内死亡的主要原因,高血压是一个关键的决定因素。过量的盐摄入是高血压和心血管疾病的一个因素。为了解决这个问题,世界卫生组织建议将每天的盐摄入量控制在5克以下,并以到2025年减少30%为目标。在马来西亚,实现这一目标的努力面临延误。当地的一项研究发现,79%的马来西亚人平均每天摄入7.9克盐,这远远高于世界卫生组织的建议。尽管做出了诸如自愿调整食品配方、强制性钠标签和公共教育运动等努力,但挑战依然存在。行业的不情愿,消费者的低意识和执法不力减慢了这些努力。本评论回顾了这些问题,并提出了加强马来西亚减盐战略的适用方法。
{"title":"World Salt Awareness Week: A call to action for reducing salt intake in Malaysia.","authors":"Yook Chin Chia, Siew Mooi Ching, Nik Sherina Hanafi","doi":"10.51866/cm.929","DOIUrl":"10.51866/cm.929","url":null,"abstract":"<p><p>Cardiovascular diseases remain a primary contributor to death worldwide, with hypertension being a key determinant. Excessive salt intake is a contributing factor of high blood pressure and cardiovascular diseases. To address this, the World Health Organization recommends keeping daily salt consumption under 5 g and aiming for a 30% decrease by 2025. In Malaysia, efforts to reach this target have faced delays. A local study found that 79% of Malaysians consume an average of 7.9 g of salt per day, which is significantly higher than the WHO's recommendations. Despite efforts such as voluntary food reformulation, mandatory sodium labelling and public education campaigns, challenges remain. Industry reluctance, low consumer awareness and inadequate enforcement slow down such efforts. This commentary reviews these issues and suggests applicable approaches to strengthen Malaysia's salt reduction strategies.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"32"},"PeriodicalIF":0.0,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12160092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case report of delayed thyroxine hypersensitivity: Challenges and management strategies. 迟发性甲状腺素超敏症1例报告:挑战与处理策略。
Q3 Nursing Pub Date : 2025-05-10 eCollection Date: 2025-01-01 DOI: 10.51866/cr.734
A Kari Halimah Hana, Ahmad Saharuddin

Herein, we present the case of a 45-year-old woman with a history of Graves' disease who underwent radioactive iodine therapy and was prescribed different oral preparations of thyroxine. Despite initial tolerance to the medication, she developed hypersensitivity reactions 3 months after consumption, which presented as urticarial rashes, erythematous maculopapular eruptions and angio-oedema. She tried a different preparation of thyroxine accompanied by antihistamines but continued having persistent reactions. This led to her discontinuation of thyroxine, resulting in overt hypothyroidism with secondary dyslipidaemia and weight gain. A diagnosis of delayed thyroxine hypersensitivity was made based on history, clinical assessment and supportive evidence from the Naranjo Adverse Drug Reaction Probability Scale.

在此,我们提出的情况下,45岁的妇女与格雷夫斯病的历史,谁接受放射性碘治疗,并规定了不同的口服甲状腺素制剂。尽管最初对该药耐受,但患者在用药3个月后出现过敏反应,表现为荨麻疹、黄斑丘疹红斑和血管水肿。她尝试了另一种甲状腺素和抗组胺药的配制,但持续出现反应。这导致她停止使用甲状腺素,导致明显的甲状腺功能减退,继发性血脂异常和体重增加。根据病史、临床评估和Naranjo药物不良反应概率量表的支持证据,诊断为迟发性甲状腺素超敏反应。
{"title":"A rare case report of delayed thyroxine hypersensitivity: Challenges and management strategies.","authors":"A Kari Halimah Hana, Ahmad Saharuddin","doi":"10.51866/cr.734","DOIUrl":"10.51866/cr.734","url":null,"abstract":"<p><p>Herein, we present the case of a 45-year-old woman with a history of Graves' disease who underwent radioactive iodine therapy and was prescribed different oral preparations of thyroxine. Despite initial tolerance to the medication, she developed hypersensitivity reactions 3 months after consumption, which presented as urticarial rashes, erythematous maculopapular eruptions and angio-oedema. She tried a different preparation of thyroxine accompanied by antihistamines but continued having persistent reactions. This led to her discontinuation of thyroxine, resulting in overt hypothyroidism with secondary dyslipidaemia and weight gain. A diagnosis of delayed thyroxine hypersensitivity was made based on history, clinical assessment and supportive evidence from the Naranjo Adverse Drug Reaction Probability Scale.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"28"},"PeriodicalIF":0.0,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12160093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144286735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Malaysian Family Physician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1